Results 61 to 70 of about 3,460 (162)

Hematological Indices as Biomarkers in Patients With Rheumatoid Arthritis but Normal ESR/CRP Receiving Biological/Targeted Synthetic DMARDs

International Journal of Rheumatic Diseases, Volume 29, Issue 7, July 2026.
ABSTRACT Objectives Evidence indicates that hematological indices, such as neutrophil‐to‐lymphocyte ratio (NLR), systemic immune‐inflammation index (SII), and neutrophil‐to‐hemoglobin and lymphocyte (NHL), are valuable for assessing disease activity in rheumatoid arthritis (RA).
Jyun‐Pei Jhou, Yin‐Hui Hou, Yu‐Sheng Chang, Jui‐Chia Chang, Wan‐Chen Shen   +4 more
wiley   +1 more source

Additional file 1 of Effectiveness of TOcilizumab in comparison to Prednisone In Rheumatoid Arthritis patients with insufficient response to disease-modifying antirheumatic drugs (TOPIRA): study protocol for a pragmatic trial

, 2020
Additional file 1.
Janneke Tekstra (3121857), Suzanne P. Linn-Rasker (5306945), Matthijs S. van der Leeuw (8675298), Reinhard Bos (576445), Faouzia Fodili (8675307), Paco M. J. Welsing (8675301), Johannes W. G. Jacobs (3177126), Anne C. A. Marijnissen (3121866), Jacob M. van Laar (8675310), Maria J. H. de Hair (8675304)   +9 more
core   +1 more source

Disease Remission: A Scoping Review With Thematic Analysis of the Scientific Literature With Implications for Chronic Rhinosinusitis

International Forum of Allergy &Rhinology, Volume 16, Issue 6, Page 615-629, June 2026.
ABSTRACT Background Remission, a term used to describe a goal of treatment for some chronic diseases, has recently been proposed for chronic rhinosinusitis (CRS). However, it is unclear what remission means for CRS and why it should serve as a goal in the present‐day treatment of CRS.
Nikhil Parail, Lynn Warner, Stacey T. Gray, Claire Hopkins, Peter H. Hwang, Sarah K. Wise, Katie M. Phillips, Ahmad R. Sedaghat   +7 more
wiley   +1 more source

Factors associated with discordance between the patient-reported Rheumatoid Arthritis Disease Activity Index (RADAI) and the Simplified Disease Activity Index (SDAI) concerning the achievement of treat-to-target goals – data from the REAL study

Background Treat-to-target (T2T) strategies in rheumatoid arthritis (RA) rely on regular assessment of disease activity using validated composite indices, with remission or low disease activity as therapeutic goals.
Ana Beatriz Vargas Santos, Licia Maria Henrique da Mota, Rina Dalva Neubarth Giorgi, Cleandro Pires de Albuquerque, Ana Paula Monteiro Gomides, Geraldo da Rocha Castelar Pinheiro, Paulo Louzada Júnior, Ivânio Alves Pereira, Sebastião Cezar Radominski, Maria Fernanda Brandão Resende Guimarães, Vitor Alves Cruz, Maria de Fátima Lobato da Cunha de da Sauma, Karina Rossi Bonfiglioli, Claiton Viegas Brenol, Alisson Aliel Vigano Pugliesi   +14 more
core   +1 more source

Serum BAFF is associated with clinical background and simplified disease activity index (SDAI) in patients with rheumatoid arthritis [PDF]

【Objectives】The B- cell activating factor belonging to TNF family (BAFF) might play a pathogenic role in rheumatoid arthritis (RA) because it has been reported that BAFF levels increases in RA serum, and anti -BAFF mAb ameliorates RA activity.
三村, 俊英, 1855, 1854, 1861, Nakajima, Kyoichi, 1860, 進藤, 靖史, 神津, 教倫, Mimura, Toshihide, Kozu, Noritsune, 1859, 1858, 1857, 中嶋, 京一, 1856, Shindo, Yasufumi   +15 more
core   +1 more source

The Effect of an Autoimmune Protocol (AIP) Diet in Adults With Rheumatoid Arthritis: A Single Arm Crossover Pilot Feasibility Study

Musculoskeletal Care, Volume 24, Issue 2, June 2026.
ABSTRACT Background Individuals with rheumatoid arthritis (RA) often ask whether dietary changes or food exclusions can reduce symptoms. The Autoimmune Protocol (AIP) diet, an elimination‐based approach, is popular on social media, with anecdotal reports of benefit, but lacks clinical evaluation in RA.
Julianne J. McNeill, Gael J. Mearns, Rebecca Grainger, Caryn Zinn   +3 more
wiley   +1 more source

SDAI as the Common Access Interface for Object-Oriented Database Management Systems

, 2010
[[abstract]]© 2000 Seventh ISPE International Conference on Concurrent Engineering: Research and Applications - This research describes the specifications for the ISO10303 Standard Data Access Interface (SDAI) and depicts the SDAI role in the integrated ...
Thu-Hua Liu;Amy J.C. Trappey;Chii-Shi Lin
core  

Impact of biological/targeted versus conventional synthetic disease‐modifying antirheumatic drugs on patient‐reported outcomes in rheumatoid arthritis

Rheumatology &Autoimmunity, Volume 6, Issue 2, Page 94-104, June 2026.
Patient‐reported outcomes (PROs) were compared among rheumatoid arthritis patients who maintained low disease activity or remission for at least 6 months based on the disease‐modifying antirheumatic drug (DMARD)administered. Even with comparable disease activity, methotrexate (MTX) group, biological/targeted synthetic DMARDs (b/tsDMARDs), particularly ...
Masafumi Sugiyama, Saki Okuda‐Tsuchimoto, Takashi Tsuchimoto, Koji Kinoshita, Itaru Matsumura   +4 more
wiley   +1 more source

Efectividad de los scores CDAI, SDAI Y RAPID-3 como criterios de remisión de la artritis reumatoide [PDF]

, 2019
Objetivo: Determinar si los scores CDAI, SDAI Y RAPID-3 son tan efectivos como el score DAS-28 en la evaluación de la remisión en pacientes con artritis reumatoide.
Flores Cecilio, Tania Iveth
core  

Scenario analyses: Differences in cost per patient achieving endpoints (ABA-1L vs. TNFi-1L).

, 2022
Difference in costs per health gain PMPM (ABA-1L –TNFi-1L). Costs per health gain PMPM were calculated by dividing total costs by the number of responders, patients in CDAI or SDAI remission for each group.
Mai Abe (10212977), Jonas Nilsson (163498), Kumiko Saka (10212980), Katsunori Ikari (137132), Eiichi Tanaka (1665016), Devender Dhanda (11689843), Hisashi Yamanaka (137140), Eisuke Inoue (400274), Moeko Ochiai (10212974), Rei Yamaguchi (10212992), Ayako Shoji (78037), Christos Papagiannopoulos (12113061), Naohiro Sugitani (10212986), Masayoshi Harigai (18940), Yuri Yoshizawa (5895275), Eri Sugano (10212983)   +15 more
core   +1 more source